4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-(dimethylamino)ethyl)benzenesulfonamide

ID: ALA1085881

PubChem CID: 46871627

Max Phase: Preclinical

Molecular Formula: C20H23N5O2S2

Molecular Weight: 429.57

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)-c2ccsc2CC3)cc1

Standard InChI:  InChI=1S/C20H23N5O2S2/c1-25(2)11-10-22-29(26,27)16-6-4-15(5-7-16)23-20-21-13-14-3-8-18-17(9-12-28-18)19(14)24-20/h4-7,9,12-13,22H,3,8,10-11H2,1-2H3,(H,21,23,24)

Standard InChI Key:  VOKVJALZAMIMIX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   14.9926   -4.1795    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4093   -4.8961    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.8217   -4.1770    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1296   -6.5573    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8460   -6.1439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8432   -5.3133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1278   -4.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5613   -6.5553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2751   -6.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9869   -6.5535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7003   -6.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6994   -5.3146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9793   -4.9034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2688   -5.3187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1285   -5.3104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4024   -6.8280    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8115   -7.5433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6181   -7.3751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4194   -6.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4240   -5.3219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7137   -4.9067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9944   -5.3142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9899   -6.1415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7047   -6.5613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8426   -4.8973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5575   -5.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2716   -4.8960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9865   -5.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2708   -4.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 14  9  1  0
 12  2  1  0
  7 20  1  0
  2 15  1  0
 19  4  1  0
  5  8  1  0
  2  1  2  0
 23 16  1  0
 16 17  1  0
 17 18  2  0
 18 24  1  0
 19 20  2  0
  8  9  1  0
  4  5  2  0
  9 10  2  0
  3  2  2  0
 10 11  1  0
  5  6  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 11 12  2  0
 15 25  1  0
 25 26  1  0
 12 13  1  0
 26 27  1  0
  6  7  2  0
 27 28  1  0
 13 14  2  0
 27 29  1  0
M  END

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LoVo (4724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 429.57Molecular Weight (Monoisotopic): 429.1293AlogP: 2.89#Rotatable Bonds: 7
Polar Surface Area: 87.22Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.63CX Basic pKa: 7.50CX LogP: 3.53CX LogD: 3.17
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.85

References

1. Crombie AL, Sum FW, Powell DW, Hopper DW, Torres N, Berger DM, Zhang Y, Gavriil M, Sadler TM, Arndt K..  (2010)  Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.,  20  (12): [PMID:20471256] [10.1016/j.bmcl.2010.04.022]

Source